Maze Therapeutics (MAZE) Income Statement: Revenue & Earnings

Maze Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Maze Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	167.50	0.00	0.00
Cost of Revenue	0.00	0.00	0.00
Gross Profit	167.50	0.00	0.00
Operating Expenses
Research & Development	83.50	73.95	88.19
Selling, General & Administrative	26.42	24.61	22.83
Operating Expenses	109.91	98.55	111.03
Operating Income	57.59	-98.55	-111.03
Other Income/Expense
Interest Income	4.65	1.97	2.03
Interest Expense	0.00	0.00	0.00
Other Income/Expense	-4.18	-3.83	-5.94
Income
Income Before Tax	53.40	-100.42	-114.94
Income Tax Expense	1.17	0.00	0.00
Net Income	52.23	-100.42	-114.94
Net Income - Continuous Operations	52.23	-100.42	-114.94
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	60.88	-94.46	-107.21
EBIT	57.59	-98.55	-111.03
Depreciation & Amortization	3.30	4.09	3.82
Earnings Per Share
Basic EPS	-	-3.00	-3.00
Diluted EPS	-	-3.00	-3.00
Basic Shares Outstanding	43.80	34.97	34.97
Diluted Shares Outstanding	43.80	35.40	35.40